Clinical Trials on Glabellar Crease
Total 10000 results
-
University of Colorado, DenverCompletedBreast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
Hebei Medical University Fourth HospitalWithdrawnTriple Negative Breast CancerChina
-
Leo W. Jenkins Cancer CenterTerminatedBreast CancerUnited States
-
German Breast GroupAstraZeneca; CelgeneCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Fudan UniversityCompleted
-
Ruijin HospitalJiangsu HengRui Medicine Co., Ltd.UnknownBreast Cancer | HER2-positive Breast Cancer | ER-positive Breast Cancer
-
University of ChicagoWithdrawnBreast Cancer | Breast Cancer Stage II | Breast Cancer Stage IIINigeria
-
AbbVieTerminated
-
Avera McKennan Hospital & University Health CenterWithdrawnMetastatic Breast Cancer | Breast Tumor | Advanced Gynecologic CancerUnited States
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul CancroTerminated
-
TriHealth Inc.TriHealth Hatton Research Institute; Bethesda North Hospital FoundationTerminatedEarly Stage Breast Cancer | Breast Tumor | Neoplasm of the BreastUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedInflammatory Breast CancerEgypt, Tunisia
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
Jules Bordet InstituteWithdrawnBreast CancerBelgium, France
-
National Taiwan University HospitalUnknownTriple Negative Breast CancerTaiwan
-
Istituti Ospitalieri di CremonaUnknownBreast Cancer | Triple Negative Breast Cancer
-
Istituti Ospitalieri di CremonaUnknownSafety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast CancersTriple Negative Breast CancerItaly
-
Cancer Institute and Hospital, Chinese Academy...Beijing Municipal Science & Technology CommissionActive, not recruitingTriple Negative Breast Cancer
-
Fudan UniversityZhejiang Cancer Hospital; Changhai Hospital; 307 Hospital of PLA; Sun Yat-sen University and other collaboratorsCompleted
-
Institut Paoli-CalmettesUnknown
-
Asan Medical CenterCompletedBreast CancerKorea, Republic of
-
Russian Academy of Medical SciencesCompletedInduction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerTriple Negative Breast CancerRussian Federation
-
Piramal Enterprises LimitedTerminated
-
Guangxi Medical UniversityUnknownStage II Breast Cancer | Stage III Breast CancerChina
-
Association Tunisienne de lutte Contre le CancerSanofi; Hoffmann-La RocheUnknownInflammatory Breast CancerTunisia
-
Summa Health SystemCompleted
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); University of Wisconsin, MadisonCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | No Evidence of Disease | One or More Positive Axillary NodesUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive and other conditionsUnited States
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Roswell Park Cancer InstituteRecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Unresectable Triple-Negative Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Advanced Triple-Negative Breast CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage I Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Nausea and VomitingUnited States
-
European Institute of OncologyRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Invasive Breast CancerItaly
-
Reshma L. Mahtani, D.O.Gilead SciencesRecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
AkesoActive, not recruitingMetastatic Triple-negative Breast Cancer | Locally Advanced Triple-negative Breast CancerChina
-
National Cancer Institute (NCI)CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | HER2/Neu PositiveUnited States, Puerto Rico
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechActive, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
Michael SimonNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7United States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Cianna Medical, Inc.TerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIC Breast Cancer | Lobular Breast Carcinoma In Situ | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Ductal Breast Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast Carcinoma and other conditionsUnited States
-
Peking Union Medical College HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States